Fidson Healthcare reports 28% increase in half-year profit

Nigerian pharmaceutical firm Fidson Healthcare recorded a 28% profit growth for the first half of 2026, driven primarily by its prescription drug segment. The company's reliance on ethical drugs for over 60% of its turnover highlights a shift toward high-margin medical products in the local market.